The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma
Abstract
To define prognostic impact of Epstein-Barr virus (EBV) infection in diffuse large B-cell lymphoma (DLBCL), we investigated EBV status in patients with DLBCL. In all, 380 slides from paraffin-embedded tissue were available for analysis by EBV-encoded RNA-1 (EBER) in situ hybridization, and 34 cases (9.0%) were identified as EBER-positive. EBER positivity was significantly associated with age greater than 60 years (P = .005), more advanced stage (P < .001), more than one extranodal involvement (P = .009), higher International Prognostic Index (IPI) risk group (P = .015), presence of B symptom (P = .004), and poorer outcome to initial treatment (P = .006). The EBER+ patients with DLBCL demonstrated substantially poorer overall survival (EBER+ vs EBER− 35.8 months [95% confidence interval (CI), 0-114.1 months] vs not reached, P = .026) and progression-free survival (EBER+ vs EBER− 12.8 months [95% CI, 0-31.8 months] vs 35.8 months [95% CI, 0-114.1 months], respectively (P = .018). In nongerminal center B-cell–like subtype, EBER in situ hybridization positivity retained its statistical significance at the multivariate level (P = .045). Nongerminal center B-cell–like patients with DLBCL with EBER positivity showed substantially poorer overall survival with 2.9-fold (95% CI, 1.1-8.1) risk for death. Taken together, DLBCL patients with EBER in situ hybridization+ pursued more rapidly deteriorating clinical course with poorer treatment response, survival, and progression-free survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Predictive Model for Aggressive Non-Hodgkin's Lymphoma
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291402 · Cited by 4,949
Hossfeld, D. K. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf146 · Cited by 4,625
Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,829
Hans, C. P. (2004) · Blood · doi:10.1182/blood-2003-05-1545 · Cited by 3,703
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
Cheson, B. D., Horning, S. J., Coiffier, B., Shipp, M. A., Fisher, R. I., Connors, J. M., Lister, T. A., Vose, J., Grillo-López, A., Hagenbeek, A., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.4.1244 · Cited by 3,486
The Non-Hodgkin's Lymphoma Classification Project (1997) · Blood · doi:10.1182/blood.v89.11.3909 · Cited by 2,461
Henderson, S., Rowe, M., Gregory, C., Croom-Carter, D., Wang, F., Longnecker, R., Kieff, E., & Rickinson, A. (1991) · Cell · doi:10.1016/0092-8674(91)90007-l · Cited by 1,168
Epstein-Barr virus: exploiting the immune system
Thorley-Lawson, D. A. (2001) · Nature Reviews Immunology · doi:10.1038/35095584 · Cited by 939
Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.
Kaye, K. M., Izumi, K. M., & Kieff, E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.9150 · Cited by 762
Alternate replication in B cells and epithelial cells switches tropism of Epstein–Barr virus
Borza, C. M., & Hutt-Fletcher, L. M. (2002) · Nature Medicine · doi:10.1038/nm0602-594 · Cited by 484
Cited by
Campo, E., Swerdlow, S. H., Harris, N. L., Pileri, S., Stein, H., & Jaffe, E. S. (2011) · Blood · doi:10.1182/blood-2011-01-293050 · Cited by 2,008
Estimating the global burden of Epstein–Barr virus-related cancers
Wong, Y., Meehan, M. T., Burrows, S. R., Doolan, D. L., & Miles, J. J. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03824-y · Cited by 314
Nicolae, A., Pittaluga, S., Abdullah, S., Steinberg, S. M., Pham, T. A., Davies-Hill, T., Xi, L., Raffeld, M., & Jaffe, E. S. (2015) · Blood · doi:10.1182/blood-2015-02-630632 · Cited by 282
Cohen, J. I., Kimura, H., Nakamura, S., Ko, Y.-H., & Jaffe, E. S. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp064 · Cited by 280
Self-citationEBV-positive diffuse large B-cell lymphoma of the elderly
Ok, C. Y., Papathomas, T. G., Medeiros, L. J., & Young, K. H. (2013) · Blood · doi:10.1182/blood-2013-03-489708 · Cited by 260
Metadata
- Authors
- Park, S., Lee, J., Ko, Y. H., Han, A., Jun, H. J., Lee, S. C., Hwang, I. G., Park, Y. H., Ahn, J. S., Jung, C. W., Kim, K., Ahn, Y. C., Kang, W. K., Park, K., & Kim, W. S.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2007-08-01
- Volume
- 110
- Issue
- 3
- Pages
- 972-978
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2090977926
- Cited by
- 320
- References
- 23
- FWCI
- 6.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. https://app.cochat.ai/papers/10.1182/blood-2007-01-067769
- The paper
- Park, S., Lee, J., Ko, Y. H., Han, A., Jun, H. J., Lee, S. C., Hwang, I. G., Park, Y. H., Ahn, J. S., Jung, C. W., Kim, K., Ahn, Y. C., Kang, W. K., Park, K., & Kim, W. S. (2007). The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood. https://doi.org/10.1182/blood-2007-01-067769
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.